Theodore L Iorio

Title: The Innovative Contributions of Theodore L. Iorio

Introduction

Theodore L. Iorio is a notable inventor based in Millis, MA (US), recognized for his significant contributions to the pharmaceutical field. With a total of 2 patents, Iorio has developed innovative formulations aimed at improving patient outcomes in cardiovascular health and attention disorders.

Latest Patents

Iorio's latest patents include a combination dosage form that contains individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin. This orally administrable pharmaceutical formulation is designed to provide a simple and convenient therapy to reduce the risk of cardiovascular events in individuals at elevated risk, including those with systemic lupus erythematosus. Additionally, it is therapeutic for individuals during or immediately following an acute myocardial infarction. Another significant patent involves a pharmaceutical dosage form for the pulsatile delivery of methylphenidate. This novel formulation allows for the release of encapsulated drug in spaced-apart "pulses," enhancing the effectiveness of treatment for attention disorders.

Career Highlights

Throughout his career, Iorio has worked with various companies, including Armaquest, Inc. and Longwood Pharmaceutical Research, Inc. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Iorio has collaborated with notable professionals in the field, including Shubha Chungi and Kamal K. Midha. These collaborations have further enriched his work and expanded the impact of his inventions.

Conclusion

Theodore L. Iorio's innovative contributions to pharmaceutical formulations demonstrate his commitment to improving healthcare outcomes. His patents reflect a deep understanding of the complexities of drug delivery and patient needs.